Algernon Pharmaceuticals Announces Emoxypine (NP-178), a Top Selling Drug in Russia, as its Lead Drug for Inflammatory Bowel Disease

World News: . []

VANCOUVER British LINK  Aug 02 2019 GLOBE NEWSWIRE -- Algernon Pharmaceuticals LINK  AGN FRANKFURT AGW OTCB BTHCF the or a clinical stage pharmaceutical development LINK  is pleased to report that its lead drug f...

More news and information about Algernon Pharmaceuticals

Published By:

Globe Newswire: 12:00 GMT Friday 2nd August 2019

Published: .

Search for other references to "algernon" on SPi News


Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
Privacy Policy | Terms and Conditions | Contact Us